| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −4.8× | −1.7× | |
| Price / Book | 1.9× | 2.0× | |
| Price / Sales | 19.5× | 3.9× | |
| Price / Free cash flow | −5.3× | −1.5× | |
| EV / EBITDA | −3.3× | −1.2× | |
| Earnings yield | −20.9% | −14.3% | |
| Free cash flow yield | −18.7% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,297.01 | +4.57% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.54 | +2.27% | $625.47B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.57 | +2.08% | $509.94B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $418.80 | +2.93% | $375.91B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.05 | +3.08% | $365.26B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.02 | +1.88% | $282.09B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.31 | +2.66% | $261.03B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $682.01 | +0.39% | $252.17B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $434.33 | +2.21% | $234.81B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.74 | +1.74% | $193.11B | 22.3× | 37.5% | +29.9% |
